Product ID:ROYCO 560
MSDS Date:10/17/2000
FSC:9150
NIIN:01-439-2070
Status Code:A
MSDS Number: CLGZQ

ROYAL LUBRICANTS COMPANY INC.

MERRY LN
EAST HANOVER, NJ 07936-0518
US

Emergency Phone: 973-887-7411

Info Phone: 973-887-7411/7410

Preparer: PRODUCT SAFETY

Cage: 07950

ROYAL LUBRICANTS COMPANY INC.

518 EAST HANOVER, NJ 07936 US

Telephone: 973-887-7411/7410

Cage: 07950

SYNTHETIC ESTER

CAS: 67762-53-2

Fraction By Weight: 0% T0 >9%

SYNTHETIC ESTER

CAS: 67762-52-1

Fraction By Weight: 0% T0 >90%

OCTYLATED N-PHENYL-1-NAPHTHYLAMINE

CAS: 68259-36-9

P,P-DIOCTYLDIPHENYLAMINE

CAS: 68411-46-1

TRICRESYL PHOSPHATE (MIXED ISOMERS)

CAS: 1330-78-5

RTECS: TD0175000

MINOR ADDITIVES (MIXTURE)

LD50 LC50 Mixture:NOT AVAILABLE FOR PRODUCT.
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:EYE CONTACT: MILDLY IRRITATING. SKIN
CONTACT: MILDLY IRRITATING. PROLONGED/REPEATED CONTACT MAY RESULT
IN ABSORPTION OF TRICRESYL PHOSPHATE WHICH COULD LEAD TO DELAYED
NEUROTOXICITY. RELEASE DURING H IGH PRESSURE MAY RESULT IN
INJECTION OF OIL INTO SKIN CAUSING LOCAL NECROSIS. INHALATION:
VAPORS, GENERATED AT HIGH TEMPERATURES ONLY, OR OIL MISTS FROM
PRODUCT MAY BE MILDLY IRRITATING TO THE NOSE, THROAT, AND
RESPIRATORY TRACT. COULD LEAD TO DELAYED NEUROTOXICITY. INGESTION:
COULD BE TOXIC IF SWALLOWED, RESULTING IN DELAYED NEUROTOXICITY.
Explanation of Carcinogenicity:THIS PRODUCT DOES NOT CONTAIN ANY
CARCINOGENS AS IDENTIFIED BY IARC, NTP, OR OSHA.
Effects of Overexposure:IRRITATION AS NOTED IN HEALTH HAZARD. DELAYED
NEUROTOXICITY MAY BE EVIDENCED BY NUMBNESS AND TINGLING OF THE
HANDS AND FEET, WEAKNESS AND CRAMPS, AND UNSTEADY GAIT. LOCAL
NEGROSIS IS EVIDENCED BY DELA YED ONSET OF PAIN AND TISSUE DAMAGE A
FEW HOURS FOLLOWING INJECTION.
Medical Cond Aggravated by Exposure:PREEXISTING EYE, SKIN, RESPIRATORY
AND NERVE DISORDERS MAY BE AGGRAVATED BY EXPOSURE TO THIS PRODUCT.

First Aid:EYE CONTACT: FLUSH WITH PLENTY OF WATER FOR 15 MIN. WHILE
HOLDING EYELIDS OPEN. GET MEDICAL ATTENTION. SKIN CONTACT: REMOVE
CONTAIMINATED CLOTHING/SHOES AND WIPE EXCESS FROM SKIN. FLUSH WITH
WATER. FO LLOW BY WASHING WITH SOAP AND WATER. IF IRRITATION
OCCURS, GET MEDICAL ATTENTION. DO NOT REUSE CLOTHING UNTIL CLEANED.
CONTAMINATE LEATHER ARTICLES, INCLUDING SHOES, CANNOT BE
DECONTAMINATED AND SHOUL D BE DESTROYED. IF MATERIAL INJECTED UNDER
SKIN, SEEK MEDICAL ATTENTION. INHALATION: MOVE TO FRESH AIR.
(CONTD. SEE " OTHER INFO.").

Flash Point Method:COC
Flash Point:=260.C, 500.F
Extinguishing Media:USE WATER FOG, FOAM, DRY CHEMICAL OR CO2, DO NOT
USE A DIRECT STREAM OF WATER. PRODUCT WILL FLOAT AND CAN BE
REIGNITED ON SURFACE OF WATER.
Fire Fighting Procedures:MATERIAL WILL NOT BURN UNLESS PREHEATED. DO
NOT ENTER CONFINED FIRE SPACE WITHOUT FULL BUNKER GEAR (HELMET WITH
FACE SHIELD, BUNKER COATS, GLOVES AND RUBBER BOOTS). INCLUDING A
POSTIIVE PRESSURE NIOSH APPROVED SELF CONTAINED BREATHING
APPARATUS. COOL FIRE EXPOSED CONTAINERS WITH WATER.
Unusual Fire/Explosion Hazard:NONE IDENTIFIED.

Spill Release Procedures:MAY BURN BUT NOT READILY IGNITABLE. WEAR
RESPIRATOR AND PROTECTIVE CLOTHING. STOP LEAK IF POSSIBLE. DIKE AND
CONTAIN SPILL. REMOVE WITH VACUUM TRUCKS OR PUMP TO STORAGE/SALVAGE
VESSELS. SOAK UP RESIDU E WITH AN ABSORBENT (CLAY, SAND OR OTHER
SUITABLE MATERIAL). DISPOSE OF PROPERLY. FLUSH AREA WITH WATER TO
REMOVE RESIDUE. TAKE UP SMALL SPILLS WITH AN ABSORBENT AND DISPOSE
OF PROPERLY.
Neutralizing Agent:NONE PROVIDED BY MFR

Handling and Storage Precautions:STORE IN A COOL DRY PLACE WITH
ADEQUATE VENTILATION. AVOID SKIN CONTACT. WASH WITH SOAP AND WATER
BEFORE EATING, DRINKING, SMOKING, APPLYING COSMETICS, OR USING
TOILET FACILITIES. LAUNDER CONTAMINATED CLOTHING BEFORE REUSE.
Other Precautions:KEEP AWAY FROM OPEN FLAMES AND HIGH TEMPERATURES.

Respiratory Protection:IF EXPOSURE MAY OR DOES EXCEED OCCUPATIONAL
EXPOSURE LIMITS USE A NIOSH-APPROVED RESPIRATOR TO PREVENT
OVEREXPOSURE. IN ACCORD WITH 29 CFR 1910.134 USE EITHER AN
ATMOSPHERE-SUPPLYING RESPIRATOR OR AN AIR-PURIFYING RESPIRATOR FOR
ORGANIC VAPORS AND PARTICULATES.
Ventilation:NONE PROVIDED BY MFR
Protective Gloves:AVOID CONTACT WITH SKIN. WEAR CHEMICAL-RESISTANT
GLOVES.
Eye Protection:AVOID CONTACT WITH EYES. WEARAFETY GLASSES OR GOGGLES AS
APPROPRIATE.
Other Protective Equipment:AVOID CONTACT WITH SKIN WEAR CHEMICAL
RESISTANT PROTECTIVE CLOTHING.
Work Hygienic Practices:AVOID SKIN CONTACT. WASH WITH SOAP AND WATER
BEFORE EATING, DRINKING, SMOKING, APPLYING COSTMETICS, OR USING
TOILET FACILITIES. LAUNDER CONTAMINATED CLOTHING BEFORE REUSE.
Supplemental Safety and Health

HCC:V6
Boiling Pt:B.P. Text:NOT AVAILABLE
Melt/Freeze Pt:M.P/F.P Text:NOT AVAILABLE
Decomp Temp:Decomp Text:NONE PROVIDED BY MFR
Vapor Pres:NOT AVAILABLE
Vapor Density:NOT AVAILA
Spec Gravity:.99 (H2O=1) APPROX.
pH:NONE PROVIDED
Viscosity:28.0 CST @ 100 DEG F
Evaporation Rate & Reference:NOT AVAILABLE
Solubility in Water:NEGLIGIBLE.
Appearance and Odor:CLEAR LIQUID.
Percent Volatiles by Volume:NONE PROVIDE
Corrosion Rate:NONE PROVIDED BY MFR

Stability Indicator/Materials to Avoid:YES
CONTACT WITH STRONG OXIDIZING AGENTS.
Stability Condition to Avoid:AVOID HEAT, FLAME.
Hazardous Decomposition Products:THERMAL DECOMPOSITION PRODUCTS
DEPENDENT ON CONDITIONS. MIXTURE OF AIRBORNE SOLID, LIQUID,
PARTICULATES, GASES EVOLVE DURING PYROLYSIS OR COMBUSTION. CARBON
MONOXIDE AND OTHER ORGANIC COMPOUNDS FORMED
Conditions to Avoid Polymerization:WILL NOT OCCUR.

Waste Disposal Methods:PLACE IN AN APPROPRIATE DISPOSAL FACILITY IN
COMPLIANCE WITH LOCAL REGULATIONS. UNDER EPA-CWA, THIS PRODUCT IS
CONSIDERED AN OIL UNDER SECTION 311. SPILLS INTO OR LEADING TO
SURFACE WATERS THAT CAUSE A SHEEN MUST BE REPORTED TO THE NATIONAL
RESPONSE CENTER, 800-424-8802.

Toxicological Information:TRICRESYL PHOSPHATE (MIXED ISOMERS) HAS BEEN
REPORTED TO PRODUCE DELAYED NEUROTOXICITY IN EXPERIMENTAL ANIMALS.
THE ORTHO ISOMER IN THEIS ADDITIVE IS KEPT BELOW A MINIMUM PURSUANT
TO MILITARY SPECIFIC ATIONS (TYPICALLY 0.03%). MOBIL HAS RECENTLY
REPORTED A STUDY TO THE EPA PURSUANT TO SECTION 8(E) OF TOSCA IN
WHICH THEY DEMONSTRATE THAT TRICRESYL PHOSPHATE (MIXED ISOMERS) AT
3% IN A LUBRICANT BASE OIL PRODUCED SIGNIFICANT SERUM AND
ERYTHROCYTE CHOLINESTERASE INHIBITION AS WELL AS NEUROPATHY TARGET
ESTERASE (NEUROTOXIC ESTERASE) INHIBITORS. OTHER STUDIES WITH TCP
IN RATS AND MICE INVOLVING ORAL (CONTD. SEE "ECOLOGICAL")

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecological:UNDER EPA-CWA, THIS PRODUCT IS CONSIDERED AN OIL UNDER
SECTION 311; SPILLS INTO OR LEADING TO SURFACE WATERS THAT CAUSE A
SHEEN MUST BE REPORTED TO THE NATIONAL RESPONSE CENTER,
800-424-8802. (CONTD. FROM "TOXICOLOGICAL") ADMINISTRATION
PRODUCED A DECREASE IN SPERM CONCENTRATION AND SPERM MOTILITY WITH
RESULTING DECREASED LITTER SIZE AND PUP VIABILITY IN FEMALES.

Transport Information:NOT HAZARDOUS BY DOT REGULATIONS.

SARA Title III Information:THIS PRODUCT IS CLASSIFIED AS A CHRONIC
(DELAYED) HEALTH HAZARD UNDER SECTION 311/312 OF SARA TITLE I I I.
Federal Regulatory Information:THE COMPONENTS OF THIS PRODUCT ARE
LISTED ON THE EPA/TSCA INVENTORY OF CHEMICAL SUBSTANCES.
State Regulatory Information:(CONTD. FROM "OTHER INFO") THAN 1 GLASS OF
WATER AND 15 CC(1 TABLESPOON) OF SYRUP OF IPECAC. IF SYMPTOMS SUCH
AS LOSS OF GAG REFLEX, CONVULSIONS OR UNCONSXIOUSNESS OCCUR BEFORE
EMESIS, GASTRIC LAVAGE SHOULD BE CONSIDERED FOLLOWING INTUBATION
WITH A CUFFED ENDOTRACHEAL TUBE.